title: Development of oseltamivir resistance during oseltamivir therapy in a child with severe 2009 H1N1 influenza.
authors.forename: Daniel
authors.initials: D
authors.lastname: Glikman
authors.forename: Zeev
authors.initials: Z
authors.lastname: Zonis
authors.forename: Musa
authors.initials: M
authors.lastname: Hindiyeh
authors.forename: Musa
authors.initials: M
authors.lastname: Hindyieh
authors.forename: Daniela
authors.initials: D
authors.lastname: Ram
authors.forename: Michal
authors.initials: M
authors.lastname: Mandelboim
authors.forename: Ella
authors.initials: E
authors.lastname: Mendelson
authors.forename: Dan
authors.initials: D
authors.lastname: Engelhard
mesh_terms: D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use; D002648:Child; D024882:Drug Resistance, Viral / Q000235:genetics*; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000187:drug effects*; D007251:Influenza, Human / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology / Q000821:virology; D007557:Israel; D008297:Male; D053139:Oseltamivir / Q000494:pharmacology / Q000627:therapeutic use; D011023:Pneumonia, Staphylococcal / Q000150:complications / Q000382:microbiology; D012720:Severity of Illness Index; D013211:Staphylococcus aureus; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D053139:Oseltamivir